Literature DB >> 30457726

Peripheral tuberculous lymphadenitis in pediatrics: 16 years of experience in a tertiary care pediatric hospital of Buenos Aires, Argentina.

Silvina E Neyro1, Isabel R Squassi2, Martín Medín3, Ana Caratozzolo4, Andrés Martínez Burkett5, María C Cerqueiro2.   

Abstract

Extrapulmonary tuberculosis accounts for 15-20 % of all clinical presentations of tuberculosis. Peripheral tuberculous lymphadenitis is the second most common presentation of extrapulmonary tuberculosis in children, after pleural tuberculosis, in Argentina. We analyzed 92 patients with peripheral tuberculous lymphadenitis seen at the Department of Tisiology of Hospital de Niños "Dr. Ricardo Gutiérrez" between August 2000 and September 2015. The patients' mean age was 8.7 ± 5 years. Nodal sites corresponded to single peripheral (31.5 %), multiple peripheral (20.6 %), and peripheral associated with deep nodes (47.8 %). Cervical lymph nodes were the most common site of involvement (80 %). In 80 % of patients previous antibiotic therapy had been administered, without response. The tuberculosis source was known in 56 %; 69 % had a positive tuberculin skin test; and 54 %, a pathological chest X-ray. Tuberculosis treatment was started on all patients based on clinical criteria, exposure and/or positive tuberculin skin test, prior to microbiological or histological confirmation. The clinical course was either healing (81.5 %), referral to a facility near home (8.7 %) or dropout (8.7 %). One patient died. Sociedad Argentina de Pediatría.

Entities:  

Keywords:  Child; Mycobacterium tuberculosis; Pediatrics; Peripheral lymphadenopathy; Tuberculous lymphadenitis

Mesh:

Substances:

Year:  2018        PMID: 30457726     DOI: 10.5546/aap.2018.eng.430

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  1 in total

1.  Role of ultrasound in the diagnosis of cervical tuberculous lymphadenitis in children.

Authors:  Tian-Zhuo Yu; Ying Zhang; Wen-Zhi Zhang; Gao-Yi Yang
Journal:  World J Pediatr       Date:  2021-09-01       Impact factor: 2.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.